Please login to the form below

Not currently logged in
Email:
Password:

Brexit and the pharmaceutical industry

News & Analysis: how the UK's departure from the EU will impact pharma and the life sciences sector

Eli Lilly shutters UK neuroscience unit, with 80 job losses expected

Eli Lilly shutters UK neuroscience unit, with 80 job losses expected

Company says decision is not related to Brexit. Eli Lilly has said it plans to shut down its Windlesham research centre in Surrey, UK, which focused on neuroscience R&D, but ... says the decision is not related to Brexit.

Latest news

More from news
Approximately 162 fully matching, plus 70 partially matching documents found.

Latest Intelligence

  • A snapshot of Crescendo Biologics A snapshot of Crescendo Biologics

    What impact will Brexit have on the business? The possibility of a no-deal Brexit and the weaker pound are not helpful for attracting key talent, especially from Europe. ... However, we continue to support our staff and are well prepared to deal with any

  • Leading AstraZeneca’s return to growth in Europe Leading AstraZeneca’s return to growth in Europe

    Naturally, Brexit is one short- to-medium-term threat, but the industry is even more focused on where the EU is heading in terms of the region’s attractiveness to inward

  • Building European biotech firms to rival those of the US Building European biotech firms to rival those of the US

    UK biotech can survive Brexit. There are enormous and well-founded concerns about the impact of a no-deal Brexit on the UK life sciences sector, and industry organisations such as ... So I’m less pessimistic about the effect of Brexit on our industry

  • A new EU in the making, what lies ahead for pharma? A new EU in the making, what lies ahead for pharma?

    French President Emmanuel Macron is said to be backing the candidacy of Michel Barnier – who of course is currently in charge of the Brexit negotiations with the UK.

  • 25 Women Leaders in UK Healthcare 25 Women Leaders in UK Healthcare

    She was made NHS England’s director for innovation and life sciences in January 2018 – at a time when fears about the impact of Brexit on the sector were creating a ... Brexit and benefit patients by unlocking the NHS’ potential.

More from intelligence
Approximately 19 fully matching, plus 33 partially matching documents found.

Latest from PMHub

  • What are you doing, Dave?

    Hey Siri, find a solution to Brexit.He might be disappointed at the banal tasks to which most AI is being put: labour-saving digital assistants that allow people to turn

  • Pegasus expands Pharma team with senior hires

    Account Director, Ed Sexton, previously led media relations for the UK BioIndustry Association, whose award-winning Brexit campaign represented more than 330 life sciences companies in the UK.

  • GENERATION Z IS FEARFUL FOR THE FUTURE OF UK HEALTH SERVICES, SAYS NEW REPORT

    At the start of a year of expected political and economic uncertainty, Brexit is their biggest worry with two-thirds (59%) believing an exit from Europe will have a negative impact ... Regardless of Brexit, both groups seem concerned about the longevity

  • Givers and Takers

    Noisy politicians who think Brexit is purely about what the UK wants as opposed to a win/win for everyone, impatient drivers who think their journey is more important than those

  • Artificial Intelligence in Healthcare

    Presently, the looming Brexit saga is casting shadows over the UK’s ability to play host to clinical trials at the frontiers of medical innovation.

More from PMHub
Approximately 5 fully matching, plus 10 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics